MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ: EXAS) today announced Cologuard has received a 2014 “Best of What’s New” award from Popular Science.
Cologuard is the first and only FDA-approved noninvasive stool DNA screening test for colorectal cancer. Approved by the FDA in August, Cologuard detects the presence of cancer and precancer by analyzing both DNA and blood in the stool.
Help employers find you! Check out all the jobs and post your resume.
Cologuard is the first and only FDA-approved noninvasive stool DNA screening test for colorectal cancer. Approved by the FDA in August, Cologuard detects the presence of cancer and precancer by analyzing both DNA and blood in the stool.
Help employers find you! Check out all the jobs and post your resume.
